As of 6 Nov 2026, Choksi Asia trades at 23.1× trailing earnings, below the industry P/E of 34.9×, and the shares are 21% below their 52-week high. It earns ROCE of 18% and ROE of 14%. It carries very little debt. It is a small-cap company with a market cap of ₹120 Cr, ranked 8th of 9 Medical Devices companies by market cap; the shares rose 99% over the past year.
- ₹210.00
- ₹223.85
- ₹206.10
- ₹211.85
- 1.7K
Health check
- ReturnsAhead
+99.0% over a year, better than 6 of 7 peers.
- Price tagCheaper
P/E 23.1 vs industry 34.9.
- GrowthStrong
Sales +309.2% a year over 3 years.
- ProfitabilityAverage
ROCE 18.4% vs peer median 12.9%.
- Balance sheetSolid
Practically debt-free, Piotroski 7 of 9.
- Red flags2 to check
Quarterly profit down 10.5% on a year ago.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹120 Cr
- Small cap
- P/E
- 23.1
- Industry 34.9
- Price to book
- 2.85
- Peers 4.08
- Dividend yield
- 0.00%
- ROE
- 13.5%
- Peers 10.7%
- ROCE
- 18.4%
- Peers 12.9%
- Debt to equity
- 0.05
- Debt ₹1.92 Cr
- EPS (TTM)
- ₹9.10
- OPM (TTM)
- 14.5%
- Net margin 11.2%
- Sales growth
- −22.5%
- Latest quarter vs a year ago
- Profit growth
- −10.5%
- Latest quarter vs a year ago
- Price to sales
- 2.57
- EV/EBITDA 17.0
Strengths and risks
Strengths
- Practically debt-free.
- P/E of 23.1 against an industry P/E of 34.9.
Risks to check
- Quarterly profit down 10.5% on a year ago.
- Quarterly sales down 22.5% on a year ago.
About Choksi Asia
Choksi Asia Limited primarily engages in the manufacture and sale of photosensitized materials and other products for the healthcare industry in India. It sells X-Ray films, lead screens, chemicals, radiation shielding materials, X-Ray generator, radiography camera, radioactive Sources and trading of other related accessories. The company also provides X-ray films and chemicals, which include laser green, laser blue, and laser chemical products; X-ray…
- Headquarters
- Mumbai
- Employees
- 12
- Sector
- Healthcare
- ISIN
- INE865B01016
- Website
- choksi-asia.com
Price range
- Avg volume (3M)
- 2.9K
- 1-year return
- plus 99.0%
- From 52-week high
- minus 21.1%
Peers · Medical Devices
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOLBIOMolbio Diagnostics | 1,339.30 | minus 4.57% | 15,434 | 92.6 | 12.91 | 16.5% | 15.6% | 20.4% | 63.7% | – | 0.00% | plus 28.6% |
| SMTSahajanand Medical Technologies | 525.95 | plus 7.83% | 5,346 | 77.3 | 7.42 | 13.3% | 10.7% | 8.4% | – | – | 0.00% | plus 39.3% |
| FISCHERFischer Medical Ventures | 24.30 | minus 2.88% | 1,698 | 10.4 | 4.08 | 12.5% | 8.9% | 12.5% | 1097.3% | – | 0.21% | minus 73.4% |
| HSILHemant Surgical Industries | 628.65 | minus 0.21% | 914 | 42.1 | 5.95 | 19.5% | 18.1% | 10.0% | 28.4% | 33.5% | 0.00% | plus 117.2% |
| UNIVPHOTOUniversus Photo Imagings | 480.00 | minus 1.49% | 525 | – | 0.65 | −9.5% | −9.5% | 5.4% | −24.3% | – | 0.00% | plus 74.8% |
| NURECANureca | 302.30 | minus 0.30% | 302 | 61.4 | 1.53 | – | 2.5% | 8.3% | 9.7% | – | 0.00% | plus 17.4% |
| EARKARTEarkart | 111.00 | minus 5.13% | 153 | 27.8 | 2.37 | 12.1% | 11.7% | 15.3% | 23.2% | 55.5% | 0.00% | minus 48.5% |
| CHOKSIChoksi Asia | 210.35 | minus 0.71% | 120 | 23.1 | 2.85 | 18.4% | 13.5% | 14.5% | 309.2% | – | 0.00% | plus 99.0% |
| Median of 7 peers | – | −1.49% | 914 | 51.8 | 4.08 | 12.9% | 10.7% | 10.0% | 25.8% | 44.5% | 0.00% | 28.6% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 11.9 | 13.3 | 12.3 | 11.9 | 9.2 | |
| 10.5 | 11.7 | 10.5 | 9.9 | 7.8 | |
| 1.4 | 1.6 | 1.8 | 2 | 1.4 | |
| 11.7% | 12.1% | 14.6% | 16.9% | 14.9% | |
| 0.3 | 0.3 | 0.5 | 0.3 | 0.3 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 1.5 | 1.7 | 2.2 | 2.2 | 1.5 | |
| 29.1% | 19.4% | 1.5% | 65.1% | 37.6% | |
| 1.1 | 1.3 | 2.1 | 0.8 | 1 | |
| 1.88 | 2.36 | 3.73 | 1.32 | 1.69 |
Profit & loss
- Sales CAGR 3Y
- +309.2%
- ROE
- 13.5%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.7 | 15.6 | 37 | 49.3 | |
| – | +2068.1% | +137.3% | +33.2% | |
| 2.2 | 15.5 | 33.1 | 42.5 | |
| −1.4 | 0.1 | 3.9 | 6.8 | |
| −200.4% | 0.4% | 10.4% | 13.8% | |
| 1.1 | 2 | 1.5 | 1.4 | |
| – | 0.4 | 0.5 | 0.4 | |
| 0.2 | 0.2 | 0.2 | 0.3 | |
| 0.1 | – | – | – | |
| −0.4 | 1.5 | 4.7 | 7.5 | |
| −7.0% | 7.4% | 34.4% | 28.9% | |
| −0.5 | 1.4 | 3.1 | 5.3 | |
| – | – | +123.4% | +72.1% | |
| -1.22 | 2.43 | 5.44 | 9.36 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 3.9 | 11.1 | 11.1 | 11.1 | |
| 11.6 | 22.4 | 25.8 | 31 | |
| – | 3.8 | 4.8 | 1.9 | |
| 2.5 | 4.5 | 5.5 | 3.4 | |
| 18 | 41.8 | 47.2 | 47.4 | |
| 5.8 | 5.6 | 6.3 | 7.1 | |
| – | – | – | 1 | |
| 3.6 | 11.2 | 9.5 | 6 | |
| 8.7 | 24.9 | 31.4 | 33.3 | |
| 18 | 41.8 | 47.2 | 47.4 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −2.5 | 2.7 | −2.9 | 0.7 | |
| 3.3 | 1.5 | 0.6 | 0.1 | |
| – | 0.5 | −1.2 | −3.4 | |
| 0.8 | 4.7 | −3.4 | −2.6 | |
| −0 | −0 | −0.8 | −1.1 | |
| −2.5 | 2.7 | −3.7 | −0.3 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.